Physicians' Knowledge of Theophylline Use: A Cross-Sectional Study from Jordan
Jordanian Physicians' Knowledge of Theophylline Use.
DOI:
https://doi.org/10.35516/jjps.v16i4.1789Keywords:
Physicians, Knowledge, Theophylline, JordanAbstract
Objective: This cross-sectional study aims to assess physicians' knowledge regarding theophylline drug and other related characteristics in Jordan.
Materials and Method: The study was conducted prospectively among physicians in Jordan. Physicians were interviewed using an online questionnaire consisting of two sections. The first section included demographics and other relevant characteristics, while the second section comprised questions about theophylline drug.
Results: A total of 385 participants completed the questionnaire. The majority of participants knew that theophylline is used in clinical practice as a bronchodilator (75.6%). Nearly 39% of participants knew that theophylline can be administered orally and intravenously. The largest share of participants (76.1%) did not know that theophylline dosage is calculated based on ideal body weight. Sixty percent of participants knew that theophylline use was not contraindicated during pregnancy. On the other hand, only 27.3% knew that theophylline use was not contraindicated during breastfeeding. The majority of participants (76.1%) had an overall intermediate knowledge of theophylline.
Conclusions: It was noted that physicians had an overall intermediate knowledge of theophylline. Physicians demonstrated unsatisfactory knowledge about theophylline’s indications, clinical use, administration, adverse effects, and other related aspects. These findings highlight the need for educational interventions and training programs to improve physicians’ knowledge of theophylline and enhance its effective and safe use in clinical practice.
References
Barnes PJ. Theophylline. American journal of respiratory and critical care medicine. 2013; 188(8): 901-6. DOI: https://doi.org/10.1164/rccm.201302-0388PP
Ma Y, Jiang D, Meng J, Li M, Zhao H, Wang Y, et al. Theophylline: a review of population pharmacokinetic analyses. Journal of Clinical Pharmacy and Therapeutics. 2016; 41(6): 594-601. DOI: https://doi.org/10.1111/jcpt.12435
Kunisaki KM, Sin DD. Methylxanthines in COPD: yes to caffeine, no to theophylline. Eur Respiratory Soc; 2021. DOI: https://doi.org/10.1183/13993003.04564-2020
Dar MH, Alam SM, Ismail K, Zaidi SAH. Low Dose Theophylline and Tiotropium Rotacap as Add on Therapy in COPD Patients-Clinical Trial. Journal of Bahria University Medical and Dental College. 2020; 10(2): 137-41. DOI: https://doi.org/10.51985/JBUMDC2020001
Niimi A, Fukunaga K, Taniguchi M, Nakamura Y, Tagaya E, Horiguchi T, et al. Executive summary: Japanese guidelines for adult asthma (JGL) 2021. Allergology International. 2023; 72(2): 207-26. DOI: https://doi.org/10.1016/j.alit.2023.02.006
Bereda G. Bronchial Asthma: Etiology, Pathophysiology, Diagnosis and Management. Austin J Pulm Respir Med. 2022; 9: 1085.
Barnes PJ. Theophylline. Pharmaceuticals. 2010; 3(3): 725-47. DOI: https://doi.org/10.3390/ph3030725
Cazzola M, Matera MG. The effect of doxofylline in asthma and COPD. Respiratory Medicine. 2020; 164: 105904. DOI: https://doi.org/10.1016/j.rmed.2020.105904
DV G, Khan MS, Aravindram A, Shivakumar H. Encapsulation of theophylline into binary blend of ethylcellulose and eudragit microparticles: development, characterization and kinetic release. Jordan Journal of Pharmaceutical Sciences. 2011; 4(3).
Hopkins ME, MacKenzie-Ross RV. Case Report: The risks associated with chronic theophylline therapy and measures designed to improve monitoring and management. BMC Pharmacology and Toxicology. 2016; 17(1): 1-4. DOI: https://doi.org/10.1186/s40360-016-0050-4
Jilani TN, Preuss CV, Sharma S. Theophylline. 2018.
Singh A, Prasad R, Gupta N. Theophylline and leukotriene modifiers: Is there any compelling role in COPD? Indian Journal of Respiratory Care. 2020; 9(2): 153. DOI: https://doi.org/10.4103/ijrc.ijrc_65_19
Journey JD, Bentley TP. Theophylline toxicity. 2018.
Farooq MU, Saeed I, Hassan SU, Zaman S, Shah M, Hussain S. Role of Low-Dose Theophylline on Functional Improvement in Patients of Moderately Severe Chronic Obstructive Pulmonary Disease. Pakistan Armed Forces Medical Journal. 2023; 73(1): 306-09. DOI: https://doi.org/10.51253/pafmj.v73i1.7254
Boylan PM, Abdalla M, Bissell B, Malesker MA, Santibañez M, Smith Z. Theophylline for the management of respiratory disorders in adults in the 21st century: a scoping review from the American College of Clinical Pharmacy Pulmonary Practice and Research Network. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2023; 43(9): 963-90. DOI: https://doi.org/10.1002/phar.2843
Haddad RM, AlSureehein SK, Alsamen GA, Khair YM, Al-Najada MM, Al-Momani JA. Efficacy and safety of oral low dose Theophylline in Jordanian patients with stable Chronic Obstructive Pulmonary Disease treated at King Hussein Medical Center. JRMS. 2016; 23(1): 34-40. DOI: https://doi.org/10.12816/0023358
Oxley-Oxland J, Freercks R, Baker D, Van der Merwe E. The characteristics and costs of severe theophylline toxicity in a tertiary critical care unit in Eastern Cape Province, South Africa. South African Medical Journal. 2022; 112(11): 866-70. DOI: https://doi.org/10.7196/SAMJ.2022.v112i11.16453
Montaño LM, Sommer B, Gomez-Verjan JC, Morales-Paoli GS, Ramírez-Salinas GL, Solís-Chagoyán H, et al. Theophylline: Old drug in a new light, application in COVID-19 through computational studies. International Journal of Molecular Sciences. 2022; 23(8): 4167. DOI: https://doi.org/10.3390/ijms23084167
Al-Rusasi A. Patient-Centeredness in Pharmaceutical Care. Jordan Journal of Pharmaceutical Sciences. 2023; 16(2): 451-. DOI: https://doi.org/10.35516/jjps.v16i2.1490
Matalqah LM, Albals D, Radaideh KM, Al-Khateeb H, Thabet RH, Abu-Ismail L, et al. Knowledge, Attitudes and Practice toward Antibiotic Use among Under and Post-Graduate Students at Yarmouk University in Jordan: A Descriptive Study. Jordan Journal of Pharmaceutical Sciences. 2022; 15(3): 378-89. DOI: https://doi.org/10.35516/jjps.v15i3.411
Rababa’h AM, Mardini AN, Ababneh MA, Rababa M, Hayajneh M. Medication errors in Jordan: A systematic review. International Journal of Critical Illness and Injury Science. 2022; 12(2): 106. DOI: https://doi.org/10.4103/ijciis.ijciis_72_21
Abdel-Qader DH, Al Meslamani AZ, El-Shara' AA, Ismael NS, Albassam A, Lewis PJ, et al. Investigating prescribing errors in the emergency department of a large governmental hospital in Jordan. Journal of Pharmaceutical Health Services Research. 2020; 11(4): 375-82. DOI: https://doi.org/10.1111/jphs.12376
Ghaferi AA, Schwartz TA, Pawlik TM. STROBE reporting guidelines for observational studies. JAMA surgery. 2021; 156(6): 577-8. DOI: https://doi.org/10.1001/jamasurg.2021.0528
Nakamura Y, Tamaoki J, Nagase H, Yamaguchi M, Horiguchi T, Hozawa S, et al. Japanese guidelines for adult asthma 2020. Allergology International. 2020; 69(4): 519-48. DOI: https://doi.org/10.1016/j.alit.2020.08.001
Shuai T, Zhang C, Zhang M, Wang Y, Xiong H, Huang Q, et al. Low-dose theophylline in addition to ICS therapy in COPD patients: A systematic review and meta-analysis. PLoS One. 2021; 16(5): e0251348. DOI: https://doi.org/10.1371/journal.pone.0251348
Goh JW, Thaw MM, Ramim JU, Mukherjee R, Ramim MJU. Theophylline Toxicity: A Differential to Consider in Patients on Long-Term Theophylline Presenting With Nonspecific Symptoms. Cureus. 2023; 15(11). DOI: https://doi.org/10.7759/cureus.48480
Raosoft I. Sample size calculator by Raosoft, Inc. 2020. 2021.
Alorfi NM, Alqurashi RS, Algarni AS. Assessment of community pharmacists’ knowledge about drug-drug interactions in Jeddah, Saudi Arabia. Frontiers in Pharmacology. 2023; 14: 1209318. DOI: https://doi.org/10.3389/fphar.2023.1209318
Osuala EC, Tlou B, Ojewole EB. Assessment of knowledge of drug-food interactions among healthcare professionals in public sector hospitals in eThekwini, KwaZulu-Natal. PLoS One. 2021; 16(11): e0259402. DOI: https://doi.org/10.1371/journal.pone.0259402
Al Mutarid M, Alhossan A, Khan T, Alyami MG, Almutared KM, Alshiban M, et al. Knowledge and Attitude of Healthcare Practitioners Toward Therapeutic Drug Monitoring Practices in the Najran Region, Kingdom of Saudi Arabia. Cureus. 2022; 14(12). DOI: https://doi.org/10.7759/cureus.32214
Matera MG, Page C, Cazzola M. Doxofylline is not just another theophylline! International Journal of Chronic Obstructive Pulmonary Disease. 2017: 3487-93. DOI: https://doi.org/10.2147/COPD.S150887
Calzetta L, Hanania NA, Dini FL, Goldstein MF, Fairweather WR, Howard WW, et al. Impact of doxofylline compared to theophylline in asthma: a pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2). Pulmonary Pharmacology & Therapeutics. 2018; 53: 20-6. DOI: https://doi.org/10.1016/j.pupt.2018.09.007
Margay SM, Farhat S, Kaur S, Teli HA. To study the efficacy and safety of doxophylline and theophylline in bronchial asthma. Journal of clinical and diagnostic research: JCDR. 2015; 9(4): FC05. DOI: https://doi.org/10.7860/JCDR/2015/12438.5743
